Drugs in development for selected autoimmune diseases U.S. 2016
This statistic shows the number of medicines in development for autoimmune diseases in the United States as of 2016, by selected types. For arthritis there were almost 76 medicines which were in development and awaiting review by the U.S. Food and Drug Administration (FDA) as of September 2016.